Managing an enterprise’s costs whilst also channeling investment and resources toward innovation and growth are constant challenges for CFOs and finance leaders – building an agile finance function that can make data-driven decisions, despite ongoing disruption, is critical for the success of any organisation.
The finance function will play a pivotal role in achieving AstraZeneca’s bold aspiration to be pioneers in science, lead in chosen disease areas and transform patient outcomes, and by 2030 deliver 15 new medicines, achieve industry-leading growth whilst being carbon negative.
Join us for this invitation-only roundtable with our keynote speaker, Mani Sharma, Group Controller & Head of Global Finance Services at AstraZeneca, alongside Vivek Saxena, Finance Leader at Genpact, to hear how CFOs can build a future-ready, insight-led function and discuss:
- Best practices for establishing the enterprise’s technology backbone and realizing its value through the power of automation and advanced analytics.
- How finance guides on Deals, M&A discussions to achieve growth, as well as proactive cost management.
- Finance’s critical role in becoming a sustainable business and managing and reporting on emissions, including Scope 3.
|18:00||Champagne Reception & Networking|
|18:30||Guests seated and welcome by FDE|
|18:50||Introductory address by Vivek Saxena, Finance Leader, Genpact|
|18:55||Keynote address by Mani Sharma, Group Controller & Head of Global Finance Services, AstraZeneca|
|19:40||Break & Networking|
|20:00||Dinner is served|